| Literature DB >> 31827018 |
Akira Sugiyama1,2, Takeshi Kawamura1,2, Toshiya Tanaka1, Hirofumi Doi1, Takefumi Yamashita1, Keiko Shinoda1, Hideaki Fujitani1, Kenzo Yamatsugu3, Yohei Shimizu3, Toshifumi Tatsumi3, Kazuki Takahashi3, Motomu Kanai3, Eiichi Mizohata4, Tatsuya Kawato4, Takefumi Doi5, Tsuyoshi Inoue5, Tatsuhiko Kodama1.
Abstract
In advanced cancer patients, malignant cells invade and disseminate within normal cells and develop resistance to therapy with additional genetic mutations, which makes radical cure very difficult. Precision medicine against advanced cancer is hampered by the lack of systems aimed at multiple target molecules within multiple loci. Here, we report the development of a versatile diagnostic and therapeutic system for advanced cancer, named the Cupid and Psyche system. Based on the strong non-covalent interaction of streptavidin and biotin, a low immunogenic mutated streptavidin, Cupid, and a modified artificial biotin, Psyche, have been designed. Cupid can be fused with various single-chain variable fragment antibodies and forms tetramer to recognize cancer cells precisely. Psyche can be conjugated to a wide range of diagnostic and therapeutic agents against malignant cells. The Cupid and Psyche system can be used in pre-targeting therapy as well as photo-immunotherapy effectively in animal models supporting the concept of a system for precision medicine for multiple targets within multiple loci.Entities:
Keywords: cancer; monoclonal antibody; photo-immunotherapy; pre-targeting; theranostics
Mesh:
Substances:
Year: 2019 PMID: 31827018 PMCID: PMC6920082 DOI: 10.2183/pjab.95.041
Source DB: PubMed Journal: Proc Jpn Acad Ser B Phys Biol Sci ISSN: 0386-2208 Impact factor: 3.493